Adaptive Biotechnologies reported a gross margin of 71.82% and a net margin of -22.65% for the quarter ended Jun 2026. These financial ratios cover 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||
| Gross Margin | 64.05% | 62.15% | 65.84% | 69.72% | 68.83% | 69.95% | 50.38% | -132.60% | 48.98% | 57.16% | 56.89% | 55.27% | 64.11% | 61.98% | 67.62% | 69.43% | 80.68% | 74.58% | 73.60% | 71.82% | |||||||||||||
| EBT Margin | -141.89% | -161.76% | -162.60% | -119.29% | -94.75% | -72.77% | -153.27% | -620.92% | -132.72% | -151.73% | -113.52% | -107.08% | -69.12% | -71.04% | -56.88% | -43.47% | 10.16% | -18.94% | -28.24% | -22.65% | |||||||||||||
| EBIT Margin | -142.71% | -162.39% | -163.30% | -120.25% | -94.98% | -70.99% | -151.92% | -621.01% | -134.38% | -155.22% | -116.45% | -109.56% | -70.27% | -71.30% | -56.45% | -42.52% | 10.95% | -17.82% | -27.10% | -22.04% | |||||||||||||
| EBITDA Margin | -142.71% | -162.39% | -163.30% | -120.25% | -94.98% | -70.99% | -98.54% | -322.32% | -78.67% | -21.75% | -67.30% | -42.42% | -24.40% | -24.86% | -17.58% | -10.31% | 32.64% | 11.84% | 17.13% | -22.04% | |||||||||||||
| Operating Margin | -142.71% | -162.39% | -163.30% | -120.25% | -94.98% | -70.99% | -151.92% | -621.01% | -134.38% | -155.22% | -116.45% | -109.56% | -70.27% | -71.30% | -56.45% | -42.52% | 10.95% | -17.82% | -27.10% | -22.04% | |||||||||||||
| Net Margin | -141.89% | -161.76% | -162.60% | -119.29% | -94.75% | -72.77% | -153.27% | -620.92% | -132.72% | -151.73% | -113.52% | -107.08% | -69.12% | -71.04% | -56.88% | -43.47% | 10.16% | -18.94% | -28.24% | -22.65% | |||||||||||||
| FCF Margin | -147.12% | -166.28% | -174.86% | -119.93% | -100.02% | -58.99% | -164.89% | -353.94% | -130.44% | -61.66% | -95.20% | -44.07% | -59.03% | -26.49% | -56.71% | -22.22% | -8.02% | 1.98% | -14.58% | -10.60% | |||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 18.42M | 18.75M | 20.13M | 19.89M | 18.06M | 15.90M | 17.16M | 19.42M | 19.23M | 16.97M | 13.87M | 13.25M | 12.58M | 10.20M | 8.56M | 8.54M | 9.17M | 9.88M | 10.51M | 10.85M | |||||||||||||
| Assets AverageAssets Avg. | 1,012.99M | 957.98M | 890.77M | 832.41M | 845.42M | 870.41M | 824.04M | 778.00M | 741.11M | 689.41M | 640.73M | 602.60M | 571.69M | 548.94M | 525.11M | 503.74M | 493.62M | 501.67M | 509.34M | 573.31M | |||||||||||||
| Invested CapitalInvested Cap. | 3.19M | 0.86M | 2.01M | 3.07M | 2.43M | 4.64M | 5.80M | ||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.14 | 0.16 | 0.17 | 0.19 | 0.20 | 0.21 | 0.22 | 0.19 | 0.19 | 0.19 | 0.21 | 0.28 | 0.31 | 0.33 | 0.36 | 0.41 | 0.51 | 0.55 | 0.58 | 0.54 | |||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -69.57 | -10.93 | -16.20 | -13.26 | -13.95 | -23.59 | -16.29 | -17.55 | -11.10 | -11.46 | -10.19 | -8.49 | 3.46 | -4.32 | -6.65 | -5.85 | |||||||||||||||||
| Debt Ratio | 0.15 | 0.18 | 0.20 | 0.21 | 0.23 | 0.24 | 0.25 | 0.26 | 0.27 | 0.27 | 0.26 | 0.26 | |||||||||||||||||||||
| Times Interest Earned | -69.57 | -10.93 | -16.20 | -13.26 | -13.95 | -23.59 | -16.29 | -17.55 | -11.10 | -11.46 | -10.19 | -8.49 | 3.46 | -4.32 | -6.65 | -5.85 | |||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||
| Enterprise Value | -415.01M | -352.95M | -363.51M | -383.73M | -508.11M | -498.26M | -440.76M | -417.30M | -371.23M | -346.52M | -309.02M | -292.05M | -243.53M | -222.52M | -193.63M | -198.05M | -212.95M | -220.77M | -210.43M | -336.51M | |||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||
| Return on SalesROS | -0.01% | -0.02% | -0.02% | -0.01% | -0.01% | -0.01% | -0.02% | -0.06% | -0.01% | -0.02% | -0.01% | -0.01% | -0.01% | -0.01% | -0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||||||||||||
| Return on Capital EmployedROCE | -21.51% | -24.75% | -29.75% | -32.39% | -30.02% | -26.32% | -26.48% | -27.78% | -30.12% | -37.75% | -39.19% | -42.39% | -41.27% | -36.05% | -32.79% | -29.42% | -19.06% | -13.87% | -11.06% | -7.71% | |||||||||||||
| Return on AssetsROA | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |